Ad is loading...
BRXUX
Price
$13.57
Change
-$0.06 (-0.44%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

BRXUX vs VTSNX

Header iconBRXUX vs VTSNX Comparison
Open Charts BRXUX vs VTSNXBanner chart's image
MFS Blended Research Intl Eq R4
Price$13.57
Change-$0.06 (-0.44%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
BRXUX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRXUX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRXUX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. BRXUX (719M). VTSNX pays higher dividends than BRXUX: VTSNX (3.29) vs BRXUX (2.65). BRXUX was incepted earlier than VTSNX: BRXUX (9 years) vs VTSNX (14 years). BRXUX is a more actively managed with annual turnover of: 56.00 vs. VTSNX (4.00). BRXUX has a lower initial minimum investment than VTSNX: BRXUX (0) vs VTSNX (5000000). BRXUX annual gain was more profitable for investors over the last year : 19.93 vs. VTSNX (10.92). BRXUX return over 5 years is better than : 35.65 vs. VTSNX (15.91).
BRXUXVTSNXBRXUX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years14 years-
Gain YTD12.0564.535266%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets719M442B0%
Annual Yield % from dividends2.653.2981%
Returns for 1 year19.9310.92183%
Returns for 3 years5.38-5.86-92%
Returns for 5 years35.6515.91224%
Returns for 10 yearsN/A29.81-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals